Stratec SE (ETR:SBS)

Germany flag Germany · Delayed Price · Currency is EUR
17.68
+0.34 (1.96%)
May 29, 2026, 5:35 PM CET
Market Cap214.92M -31.6%
Revenue (ttm)250.86M -2.6%
Net Income-242.00K
EPS-0.02
Shares Out 12.16M
PE Ration/a
Forward PE12.37
Dividend0.60 (3.39%)
Ex-Dividend DateJun 24, 2026
Volume15,919
Open17.34
Previous Close17.34
Day's Range17.34 - 17.92
52-Week Range16.30 - 33.10
Beta0.79
AnalystsBuy
Price Target25.40 (+47.06%)
Earnings DateAug 14, 2026

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is h... [Read more]

Sector Healthcare
Founded 1979
Employees 1,343
Stock Exchange Deutsche Börse Xetra
Ticker Symbol SBS
Full Company Profile

Financial Performance

Financial Statements

News

Stratec SE Earnings Call Transcript: Q1 2026

Q1 2026 saw lower revenue and earnings due to timing shifts and product mix, but cash flow and leverage improved. Guidance for 2026 is confirmed, with growth and margin recovery expected in H2, and long-term targets remain intact.

20 days ago - Transcripts

Stratec SE Quarterly report: Q1 2026

Stratec SE has published its Q1 2026 quarterly earnings report on May 11, 2026.

20 days ago - Filings

Stratec SE Earnings release: Q1 2026

Stratec SE released its Q1 2026 earnings on May 11, 2026, summarizing the period's financial results.

20 days ago - Filings

Stratec SE Slides: Q1 2026

Stratec SE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 11, 2026.

20 days ago - Filings

Stratec SE Earnings Call Transcript: Q4 2025

2025 saw stable revenue but lower margins amid geopolitical and supply chain challenges, with significant one-time charges impacting net income. Growth is expected to resume in 2026, driven by new product launches and efficiency gains, with margin recovery targeted by 2028.

4 weeks ago - Transcripts

Stratec SE Annual report: Q4 2025

Stratec SE has published its Q4 2025 annual report on April 28, 2026.

4 weeks ago - Filings

Stratec SE Earnings release: Q4 2025

Stratec SE released its Q4 2025 earnings on April 28, 2026, summarizing the period's financial results.

4 weeks ago - Filings

Stratec SE Slides: Q4 2025

Stratec SE has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on April 28, 2026.

4 weeks ago - Filings

Stratec SE Earnings Call Transcript: Q3 2025

Sales grew 2.5% year-over-year to EUR 175.6 million, with margin pressure from product mix and supply chain issues. Full-year guidance is for flat sales and lower margins, but Q4 is expected to improve. New partnerships, a syndicated loan, and market stabilization support a positive long-term outlook.

7 months ago - Transcripts

Stratec SE Quarterly report: Q3 2025

Stratec SE has published its Q3 2025 quarterly earnings report on November 7, 2025.

7 months ago - Filings

Stratec SE Slides: Q3 2025

Stratec SE has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 7, 2025.

7 months ago - Filings

Stratec SE Earnings Call Transcript: Q2 2025

H1 2025 saw 5.2% sales growth, stable gross margin, but lower EBIT margin due to FX and one-offs. Full-year guidance is confirmed, with H2 expected to be back-end loaded and driven by Analyzer Systems sales acceleration. M&A and refinancing activities are ongoing.

10 months ago - Transcripts

Stratec SE Quarterly report: Q2 2025

Stratec SE has published its Q2 2025 quarterly earnings report on August 19, 2025.

10 months ago - Filings

Stratec SE Slides: Q2 2025

Stratec SE has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 19, 2025.

10 months ago - Filings

Stratec SE Transcript: Health Care Conference

Recurring revenue from consumables and service parts now surpasses instrument sales, driven by a large installed base and post-COVID market dynamics. Growth is expected to resume in 2025 as replacement cycles and innovation in diagnostics drive demand, with a continued focus on M&A and cost discipline.

11 months ago - Transcripts

Stratec SE Slides: Investor Presentation

Stratec SE has posted slides in relation to its latest quarterly earnings report, which was published on June 6, 2025.

1 year ago - Filings